Purdue sues its insurers for $3.3bn of opioid litigation coverage
Purdue Pharma has sued its insurers, seeking a ruling that it is entitled to $3.3bn of coverage under its policies to help pay some of the liability the OxyContin maker faces from thousands of opioid mass tort claims.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below